59% Revenue Plunge for Sensus Healthcare in Q1 as Key Customer Departs
SRTS sits 27% above its 52-week low of $3.03.
Summary
Sensus Healthcare reported a significant 59% year-over-year revenue decline in Q1, falling to $3.39 million and substantially missing analyst expectations of $5.32 million. The company also posted a net loss of $2.63 million and missed adjusted EBITDA estimates. This steep revenue drop is primarily attributed to the absence of sales to its largest customer and fewer units shipped. This exacerbates the customer concentration risk and negative revenue trend highlighted in the company's recent 10-K, which reported a 34% revenue decrease for the full year 2025. While management noted increased customer activity and diversification efforts, along with a positive outlook from new CPT codes, the immediate financial results are highly concerning for a company of its size. Traders will be closely monitoring whether the company's strategic initiatives can effectively mitigate the impact of losing its largest customer and reverse the severe revenue contraction in upcoming quarters.
At the time of this announcement, SRTS was trading at $3.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $67.7M. The 52-week trading range was $3.03 to $5.92. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.